p53 expression and prognosis in gastric carcinoma

International Journal of Cancer

Volumn 50, Issue 6, 1992, Pages 859-862

  Martin, Hilary M ^a   Filipe, M Isabel ^a   Morris, Richard W ^a   Lane, David P ^b   Silvestre, Frederico ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE;

COMPARATIVE STUDY; GENES, P53; HUMAN; IMMUNOENZYME TECHNIQUES; LIFE TABLES; PROGNOSIS; PROTEIN P53; STOMACH NEOPLASMS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0026594506     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910500604     Document Type: Article

References (29)

1. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies
2. Patterns of expression of p53 tumour suppressor in human breast tissues and tumour. in situ and in vitro
3. Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer
4. Selective G‐to‐T mutations of p53 gene in hepatocellular carcinoma from Southern Africa
5. Refractoriness to chemotherapy and poor survival related to abnormalities of chromosome 17 and 7 in lymphomas
6. p53 expression in breast cancer
7. Mutations in the p53 gene are frequent in primary, resected non‐small‐cell lung cancer
8. Regression models and life tables
9. The p53 protooncogene can act as a suppressor of transformation
10. p53 mutations in human cancers
11. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
12. Increased expression of mutant forms of p53 oncogene in primary lung cancer
13. Location of the gene for human p53 tumour antigen to band 17 p13
14. p53: oncogene or anti‐oncogene
15. The two histological main types of gastric carcinoma: diffuse and so‐called intestinal‐type carcinomas: an attempt at a histoclinical classification
16. Modulation of p53‐gene expression and cytokeratin 18 in retinoid‐mediated invasion‐suppressed lung carcinoma cells
17. The p53 tumour‐suppressor gene
18. Gastric carcinoma—a pathobiologic classification
19. Allelic loss of chromosome 17p distinguishes high‐grade from low‐grade transitional‐cell carcinomas of the bladder
20. Histological typing of gastric and oesophageal tumours
21. Induction of the metastatic phenotype by transfection of the nuclear oncogene p53: increases in cytoplasmic diacylglycerol levels and reduction in class‐I‐MHC antigen expression are not sufficient to explain the changes in metastatic capacities
22. Simultaneous monitoring of p53 protein and DNA content of colorectal adenocarcinoma by flow cytometry
23. p53: a frequent target for genetic abnormalities in lung cancer
24. Detection of frequent p53‐gene mutations in primary gastric cancer by cell sorting and polymerase‐chain‐reaction single‐strand conformation polymorphism analysis
25. p53 gene mRNA expression and chromosome 17p allele loss in breast cancer
26. Biological characterisation and oncogene expression in human colorectal carcinoma cell lines
27. Allelotype of colorectal carcinomas